1. Home
  2. INMD vs PCRX Comparison

INMD vs PCRX Comparison

Compare INMD & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InMode Ltd.

INMD

InMode Ltd.

N/A

Current Price

$13.58

Market Cap

842.0M

Sector

Health Care

ML Signal

N/A

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$23.24

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INMD
PCRX
Founded
2008
2006
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
842.0M
1.0B
IPO Year
2018
2010

Fundamental Metrics

Financial Performance
Metric
INMD
PCRX
Price
$13.58
$23.24
Analyst Decision
Hold
Strong Buy
Analyst Count
6
5
Target Price
$16.75
$37.60
AVG Volume (30 Days)
818.6K
740.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
107.44
EPS
N/A
0.16
Revenue
N/A
$541,533,000.00
Revenue This Year
$1.70
$9.77
Revenue Next Year
$3.99
$9.71
P/E Ratio
$10.11
$147.31
Revenue Growth
N/A
26.04
52 Week Low
$12.72
$18.80
52 Week High
$19.09
$27.99

Technical Indicators

Market Signals
Indicator
INMD
PCRX
Relative Strength Index (RSI) 45.21 55.05
Support Level $13.28 $23.10
Resistance Level $14.80 $23.82
Average True Range (ATR) 0.28 1.06
MACD -0.05 0.08
Stochastic Oscillator 58.85 77.96

Price Performance

Historical Comparison
INMD
PCRX

About INMD InMode Ltd.

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: